Cargando…
Liraglutide relieves cardiac dilated function than DPP‐4 inhibitors
INTRODUCTION: Diabetes mellitus is a progressive disease with cardiovascular complications. This study evaluated the effects of liraglutide, a glucagon‐like peptide‐1 analogue and the dipeptidyl peptidase 4 inhibitors sitagliptin and linagliptin on cardiac function in type 2 diabetes patients with r...
Autores principales: | Hiramatsu, Takeyuki, Asano, Yuko, Mabuchi, Masatsuna, Imai, Kentaro, Iguchi, Daiki, Furuta, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175244/ https://www.ncbi.nlm.nih.gov/pubmed/30054920 http://dx.doi.org/10.1111/eci.13007 |
Ejemplares similares
-
Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment
por: Hiramatsu, Takeyuki, et al.
Publicado: (2020) -
Liraglutide and DPP-4 inhibitors – side effects comparative clinical study
por: TIMOFTE, LUMINIŢA, et al.
Publicado: (2013) -
Long-term renal survival of γ3-heavy chain deposition disease: a case report
por: Katsuno, Takayuki, et al.
Publicado: (2017) -
GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy
por: Shiraki, Aya, et al.
Publicado: (2019) -
The pain-relieving effects of lactoferrin on oxaliplatin-induced neuropathic pain
por: FUJIMURA, Takeshi, et al.
Publicado: (2020)